No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life.
Plomgaard AM, Alderliesten T, van Bel F, Benders M, Claris O, Cordeiro M, Dempsey E, Fumagalli M, Gluud C, Hyttel-Sorensen S, Lemmers P, Pellicer A, Pichler G, Greisen G.
Plomgaard AM, et al. Among authors: van bel f.
Acta Paediatr. 2019 Feb;108(2):275-281. doi: 10.1111/apa.14463. Epub 2018 Jul 5.
Acta Paediatr. 2019.
PMID: 29908039
Free PMC article.
Clinical Trial.